ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.4K |
2.0M |
0 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.4K |
2.0M |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.4K |
2.0M |
6 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day 2024 - scurvy dogs o' the ASX
|
|
Leroy65
|
124 |
41K |
0 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
124
|
41K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Leroy65
|
706 |
258K |
15 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
706
|
258K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
New Player
|
|
Leroy65
|
81 |
21K |
1 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
81
|
21K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.4K |
2.0M |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Leroy65
|
4.4K |
2.0M |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Leroy65
|
46 |
18K |
15 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Initial Director's Interest Notice
|
|
Leroy65
|
13 |
4.0K |
7 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
13
|
4.0K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Leroy65
|
670 |
264K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
670
|
264K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
Leroy65
|
71 |
27K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
71
|
27K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Leroy65
|
327 |
110K |
6 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
327
|
110K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
Leroy65
|
71 |
27K |
11 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
71
|
27K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Selected for Major OA Conference Presentations
|
|
Leroy65
|
35 |
12K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
35
|
12K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
2 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
4 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
3 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
7 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
10 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
bene- what is PPS? What disease...what side effects. what.......
|
|
Leroy65
|
20 |
6.8K |
9 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
20
|
6.8K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
4 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
4 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
AGM Meeting
|
|
Leroy65
|
92 |
34K |
4 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
92
|
34K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
10 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
1.2K
|
429K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
Leroy65
|
75 |
26K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
75
|
26K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
NEU
|
|
Leroy65
|
16 |
7.2K |
4 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
16
|
7.2K
|
4
|
|
ASX - By Stock
|
PAR |
NEU
|
|
Leroy65
|
16 |
7.2K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
16
|
7.2K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
10 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
6 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
8 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
5 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
2 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Leroy65
|
1.2K |
429K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.2K
|
429K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Mozz Research 2023
|
|
Leroy65
|
15 |
6.3K |
11 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
15
|
6.3K
|
11
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Leroy65
|
26 |
13K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
26
|
13K
|
1
|
|
ASX - By Stock
|
PAR Biotech |
Re:
Lorecivivint
|
|
Leroy65
|
26 |
13K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
26
|
13K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
Leroy65
|
151 |
48K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
151
|
48K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
Leroy65
|
151 |
48K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
151
|
48K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
Leroy65
|
95 |
29K |
2 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
29K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
Leroy65
|
95 |
29K |
9 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
95
|
29K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
Leroy65
|
151 |
48K |
27 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
151
|
48K
|
27
|
|